22 February 2002
Cytomegalovirus infection and atherogenesis.
Lech Torliński, Marzena Wal, Joanna Bogaczyńska-Staniewicz, Andrzej SzkaradkiewiczMed Sci Monit 2002; 8(2): CR104-107 :: ID: 420932
Abstract
BACKGROUND: Experimental studies and clinical observations indicate theimportance of active CMV infection in the development of atherosclerosis. Our research constituted anattempt to evaluate the components of lipid metabolism (total cholesterol and its fractions, triglycerides)in children with active CMV infection. MATERIAL/METHODS: The research involved 45 children with activeprimary or secondary CMV infection. The diagnosis was established by measuring anti-CMV serum antibodies(IgM and IgG) using the Enzyme-Linked Fluorescent Assay (ELFA) technique, and by detecting CMV-DNA usingthe PCR technique. On the basis of diagnostic tests, the children were allocated to one of two groups.The first group of 15 children manifested primary active infection with CMV. The other group consistedof 30 children diagnosed with secondary active CMV infection. RESULTS: In the first group, the mean valuesof the serum lipid profile were as follows: total cholesterol--142 +/- 32.9 mg/dl; HDL-cholesterol:--23.4 +/- 8.6 mg/dl; LDL-cholesterol--97.8 +/- 30.9 mg/dl; triglycerides--83 +/- 15.5 mg/dl. In the secondgroup of children, the mean values of serum lipid profile were as follows: total cholesterol-- 142.5+/- 44.2 mg/dl; HDL-cholesterol--21.4 +/- 10.8 mg/dl, LDL-cholesterol--87.1 +/- 35.3 mg/dl; triglycerides--101.7+/- 31.2 mg/dl. In all these children, the values of total cholesterol, LDL-cholesterol, and triglyceridesconformed to published norms, while HDL-cholesterol was significantly below normal. CONCLUSIONS: Theresults we obtained point to dyslipidemia in the course of active CMV infection, which may be of pathogeneticsignificance at any stage of atherogenesis.
Keywords: Arteriosclerosis, Child, Child, Preschool, Cholesterol, Triglycerides
Editorial
01 May 2024 : Editorial
Editorial: First Regulatory Approval for Adoptive Cell Therapy with Autologous Tumor-Infiltrating Lymphocytes (TILs) – Lifileucel (Amtagvi)DOI: 10.12659/MSM.944927
Med Sci Monit 2024; 30:e944927
In Press
12 Mar 2024 : Clinical Research
Tissue Inhibitors of Metalloproteinase 1 (TIMP-1) and 3 (TIMP-3) as New Markers of Acute Kidney Injury Afte...Med Sci Monit In Press; DOI: 10.12659/MSM.943500
12 Mar 2024 : Review article
Optimizing Behçet Uveitis Management: A Review of Personalized Immunosuppressive StrategiesMed Sci Monit In Press; DOI: 10.12659/MSM.943240
12 Mar 2024 : Clinical Research
Metabolomic Alterations in Methotrexate Treatment of Moderate-to-Severe PsoriasisMed Sci Monit In Press; DOI: 10.12659/MSM.943360
14 Mar 2024 : Clinical Research
Renal Dysfunction Increases Risk of Adverse Cardiovascular Events in 5-Year Follow-Up Study of Intermediate...Med Sci Monit In Press; DOI: 10.12659/MSM.943956
Most Viewed Current Articles
17 Jan 2024 : Review article
Vaccination Guidelines for Pregnant Women: Addressing COVID-19 and the Omicron VariantDOI :10.12659/MSM.942799
Med Sci Monit 2024; 30:e942799
14 Dec 2022 : Clinical Research
Prevalence and Variability of Allergen-Specific Immunoglobulin E in Patients with Elevated Tryptase LevelsDOI :10.12659/MSM.937990
Med Sci Monit 2022; 28:e937990
16 May 2023 : Clinical Research
Electrophysiological Testing for an Auditory Processing Disorder and Reading Performance in 54 School Stude...DOI :10.12659/MSM.940387
Med Sci Monit 2023; 29:e940387
01 Jan 2022 : Editorial
Editorial: Current Status of Oral Antiviral Drug Treatments for SARS-CoV-2 Infection in Non-Hospitalized Pa...DOI :10.12659/MSM.935952
Med Sci Monit 2022; 28:e935952